| Jaimin Pinakin Amin, MD | |
|
900 Rand Rd Ste 120, Des Plaines, IL 60016-2359 | |
| (312) 767-3244 | |
| Not Available |
| Full Name | Jaimin Pinakin Amin |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 13 Years |
| Location | 900 Rand Rd Ste 120, Des Plaines, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588955066 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 036137739 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Loyola University Medical Center | Maywood, IL | Hospital |
| Advocate Trinity Hospital | Chicago, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midwest Digestive Health And Nutrition, Pllc | 2769830389 | 16 |
| Loyola University Medical Center | 3779488903 | 863 |
News Archive
Age, male sex, obesity, and underlying illness have emerged as risk factors for severe covid-19 or death in the UK, according to the largest cohort study to date published by The BMJ today.
Results from a clinical study presented at the 2009 American Society of Anesthesiologists (ASA) Meeting suggest that elevated preoperative levels of the B-type natriuretic peptide (BNP) biomarker may predict hospital length of stay and mortality after primary coronary artery bypass graft surgery better than measurements of elevated postoperative BNP levels.
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
Adverse drug reactions are harmful to patients and a major burden for healthcare providers, governments and the pharmaceutical industry. But promising new breakthroughs in drug development and health monitoring may enhance drug safety in the future, according to an editorial to be published in the next edition of the British Journal of Clinical Pharmacology.
› Verified 6 days ago
| Entity Name | Loyola University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336159961 PECOS PAC ID: 3779488903 Enrollment ID: O20031202000027 |
News Archive
Age, male sex, obesity, and underlying illness have emerged as risk factors for severe covid-19 or death in the UK, according to the largest cohort study to date published by The BMJ today.
Results from a clinical study presented at the 2009 American Society of Anesthesiologists (ASA) Meeting suggest that elevated preoperative levels of the B-type natriuretic peptide (BNP) biomarker may predict hospital length of stay and mortality after primary coronary artery bypass graft surgery better than measurements of elevated postoperative BNP levels.
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
Adverse drug reactions are harmful to patients and a major burden for healthcare providers, governments and the pharmaceutical industry. But promising new breakthroughs in drug development and health monitoring may enhance drug safety in the future, according to an editorial to be published in the next edition of the British Journal of Clinical Pharmacology.
› Verified 6 days ago
| Entity Name | Rush University Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093819542 PECOS PAC ID: 5496658874 Enrollment ID: O20040202000228 |
News Archive
Age, male sex, obesity, and underlying illness have emerged as risk factors for severe covid-19 or death in the UK, according to the largest cohort study to date published by The BMJ today.
Results from a clinical study presented at the 2009 American Society of Anesthesiologists (ASA) Meeting suggest that elevated preoperative levels of the B-type natriuretic peptide (BNP) biomarker may predict hospital length of stay and mortality after primary coronary artery bypass graft surgery better than measurements of elevated postoperative BNP levels.
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
Adverse drug reactions are harmful to patients and a major burden for healthcare providers, governments and the pharmaceutical industry. But promising new breakthroughs in drug development and health monitoring may enhance drug safety in the future, according to an editorial to be published in the next edition of the British Journal of Clinical Pharmacology.
› Verified 6 days ago
| Entity Name | Midwest Digestive Health & Nutrition, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477241750 PECOS PAC ID: 2769830389 Enrollment ID: O20231121000521 |
News Archive
Age, male sex, obesity, and underlying illness have emerged as risk factors for severe covid-19 or death in the UK, according to the largest cohort study to date published by The BMJ today.
Results from a clinical study presented at the 2009 American Society of Anesthesiologists (ASA) Meeting suggest that elevated preoperative levels of the B-type natriuretic peptide (BNP) biomarker may predict hospital length of stay and mortality after primary coronary artery bypass graft surgery better than measurements of elevated postoperative BNP levels.
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
Adverse drug reactions are harmful to patients and a major burden for healthcare providers, governments and the pharmaceutical industry. But promising new breakthroughs in drug development and health monitoring may enhance drug safety in the future, according to an editorial to be published in the next edition of the British Journal of Clinical Pharmacology.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jaimin Pinakin Amin, MD 1400 S Michigan Ave Apt 1203, Chicago, IL 60605-3720 Ph: (312) 767-3244 | Jaimin Pinakin Amin, MD 900 Rand Rd Ste 120, Des Plaines, IL 60016-2359 Ph: (312) 767-3244 |
News Archive
Age, male sex, obesity, and underlying illness have emerged as risk factors for severe covid-19 or death in the UK, according to the largest cohort study to date published by The BMJ today.
Results from a clinical study presented at the 2009 American Society of Anesthesiologists (ASA) Meeting suggest that elevated preoperative levels of the B-type natriuretic peptide (BNP) biomarker may predict hospital length of stay and mortality after primary coronary artery bypass graft surgery better than measurements of elevated postoperative BNP levels.
Algeta ASA, the cancer therapeutics company, announces that the first clinical center in the US, the Tulane Cancer Center, New Orleans, has started randomizing patients in the phase III clinical study of Alpharadin in men with castration-resistant (also known as hormone-refractory) prostate cancer (CRPC) that has metastasized to the skeleton.
Adverse drug reactions are harmful to patients and a major burden for healthcare providers, governments and the pharmaceutical industry. But promising new breakthroughs in drug development and health monitoring may enhance drug safety in the future, according to an editorial to be published in the next edition of the British Journal of Clinical Pharmacology.
› Verified 6 days ago
Steven Hendler, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 900 Rand Rd Ste 120, Des Plaines, IL 60016 Phone: 312-767-3244 | |
Dr. Zuie Wakade, Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 900 Rand Rd Ste 120, Des Plaines, IL 60016 Phone: 312-767-3244 | |
Rajan H Patel, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 9301 Golf Rd, Suite 302, Des Plaines, IL 60016 Phone: 847-296-8151 Fax: 847-296-3915 | |
Bela D Desai, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 77 Rand Rd, Des Plaines, IL 60016 Phone: 847-803-1344 Fax: 847-803-3791 | |
Gary K Artinian, MD Gastroenterology Medicare: Medicare Enrolled Practice Location: 77 Rand Rd, Des Plaines, IL 60016 Phone: 847-298-0310 Fax: 847-298-5939 | |
Dr. Mukund Venu, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 900 Rand Rd Ste 120, Des Plaines, IL 60016 Phone: 312-767-3244 | |
Peter Werner, M.D. Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 150 N River Rd, Suite 210, Des Plaines, IL 60016 Phone: 847-759-4060 Fax: 847-759-4066 |